UK study tracks Real-World impact of nerve stimulation on epilepsy
NCT ID NCT04779814
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study followed 97 people with drug-resistant epilepsy in the UK who had a vagus nerve stimulation (VNS) device implanted. Researchers looked at medical records and patient surveys to see how the therapy affected hospital visits and seizures over time. The goal was to understand real-world outcomes, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bristol Royal Hospital For Children
Bristol, United Kingdom
-
Nottingham Children's Hospital
Nottingham, United Kingdom
-
Oxford University Hospital NHSFT
Oxford, United Kingdom
-
Queen Elizabeth Hospital Birmingham
Birmingham, United Kingdom
-
The Walton Centre
Liverpool, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain surgery meets brain science: probing how a memory-related chemical system influences cognition
- Spotting the warning signs of drug-resistant epilepsy in children
- Could a simple conversation change how doctors treat mental illness?
- Eye scans may spot Epilepsy's silent brain damage
- Triple PET imaging could sharpen epilepsy surgery targeting
- AI-Powered portable MRI could bring epilepsy diagnosis to millions who lack access